Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues

Roeland Zoutendijk; Milan Sonneveld; Jurriën Reijnders; Hanneke van Vuuren; Paula Biesta; Bettina Hansen; Andre Boonstra; HLA Janssen

doi:10.1111/jvh.12033

Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	322-327
Number of pages	6
Journal	Journal of Viral Hepatitis
Volume	20
Issue number	5
DOIs	https://doi.org/10.1111/jvh.12033
Publication status	Published - 2013

Research programs

EMC MM-04-20-01
EMC MM-04-20-02-A

Access to Document

10.1111/jvh.12033

http://hdl.handle.net/1765/39922

Cite this

@article{32637391d14b4880a810471ef1cef4ed,

title = "Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues",

author = "Roeland Zoutendijk and Milan Sonneveld and Jurri{\"e}n Reijnders and \{van Vuuren\}, Hanneke and Paula Biesta and Bettina Hansen and Andre Boonstra and HLA Janssen",

year = "2013",

doi = "10.1111/jvh.12033",

language = "Undefined/Unknown",

volume = "20",

pages = "322--327",

journal = "Journal of Viral Hepatitis",

issn = "1352-0504",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

Zoutendijk, R, Sonneveld, M , Reijnders, J , van Vuuren, H, Biesta, P, Hansen, B , Boonstra, A & Janssen, HLA 2013, 'Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues', Journal of Viral Hepatitis, vol. 20, no. 5, pp. 322-327. https://doi.org/10.1111/jvh.12033

Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues. / Zoutendijk, Roeland; Sonneveld, Milan ; Reijnders, Jurriën et al.
In: Journal of Viral Hepatitis, Vol. 20, No. 5, 2013, p. 322-327.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues

AU - Zoutendijk, Roeland

AU - Sonneveld, Milan

AU - Reijnders, Jurriën

AU - van Vuuren, Hanneke

AU - Biesta, Paula

AU - Hansen, Bettina

AU - Boonstra, Andre

AU - Janssen, HLA

PY - 2013

Y1 - 2013

U2 - 10.1111/jvh.12033

DO - 10.1111/jvh.12033

M3 - Article

C2 - 23565614

SN - 1352-0504

VL - 20

SP - 322

EP - 327

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

IS - 5

ER -